Clinical trial
Phase 2 Open-Label Study of Safety and Efficacy Trial of CXA-10 in Pulmonary Arterial Hypertension
NCT04125745 is registered in ClinicalTrials.gov with Gladwin, Mark, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Open-Label Study of Safety and Efficacy Trial of CXA-10 in Pulmonary Arterial Hypertension
- Lead sponsor
- Gladwin, Mark, MD
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 31, 2019
- Completion date
- December 1, 2020
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.